Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety test of C5a anaphylatoxin inhibitory peptide AcPepA
jRCT1091220027Phase 1Completed
- Sponsor
- Fukushimura Hospital
- Start
- Apr 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label trial of AcPepA (3 arms), sponsored by Fukushimura Hospital. Primary endpoints: Safety vital signs, Electrocardiogram (ECG) and 4 more. Started Apr 2009; status: completed.
02
Drugs
AcPepA
Beyond the preview
Go deeper on jRCT1091220027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220027.